In the event of an inadvertent temperature excursion the following data may be used:

The vaccine components are stable at temperatures up to 25°C for a cumulative time of 168 hours or temperatures up to 37°C for a cumulative time of 72 hours.

Temperature excursions from 0°C to 2°C do not impact the quality of the product.

The product can be returned to the fridge and no change in expiry date is required if exposed to the above conditions.

Contact GSK in cases where additional stability data is required. Refer to the electronic medicines compendium (eMC) at https://www.medicines.org.uk for company contact details.

Public Health England has guidance on responding to errors in vaccine storage, handling and administration.

In the event of an inadvertent temperature excursion the following data may be used:

The vaccine components are stable at temperatures up to 25°C for a cumulative time of 168 hours or temperatures up to 37°C for a cumulative time of 72 hours.

Temperature excursions from 0°C to 2°C do not impact the quality of the product.

The product can be returned to the fridge and no change in expiry date is required if exposed to the above conditions.

Contact GSK in cases where additional stability data is required. Refer to the electronic medicines compendium (eMC) at https://www.medicines.org.uk for company contact details.

Public Health England has guidance on responding to errors in vaccine storage, handling and administration.

In the event of an inadvertent temperature excursion the following data may be used:

The vaccine components are stable for a cumulative time of 72 hours when stored at temperatures from 8°C to 25°C or 0°C and 2°C.

Please also refer to the manufacturer’s product literature for recommended storage information at https://www.medicines.org.uk

Public Health England has guidance on responding to errors in vaccine storage, handling and administration.